Price T Rowe Associates Inc Penumbra Inc Transaction History
Price T Rowe Associates Inc
- $935 Billion
- Q3 2025
A detailed history of Price T Rowe Associates Inc transactions in Penumbra Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 1,794,267 shares of PEN stock, worth $500 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
1,794,267
Previous 1,374,001
30.59%
Holding current value
$500 Million
Previous $353 Million
28.9%
% of portfolio
0.05%
Previous 0.04%
Shares
20 transactions
Others Institutions Holding PEN
# of Institutions
472Shares Held
30.6MCall Options Held
309KPut Options Held
95.9K-
Black Rock Inc. New York, NY4.26MShares$1.19 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.84MShares$1.07 Billion0.02% of portfolio
-
State Street Corp Boston, MA1.16MShares$324 Million0.01% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il971KShares$270 Million0.04% of portfolio
-
Baillie Gifford & CO909KShares$253 Million0.18% of portfolio
About Penumbra Inc
- Ticker PEN
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,888,400
- Market Cap $10.6B
- Description
- Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...